Cellosaurus logo
expasy logo

Cellosaurus MHHi002-A-1 (CVCL_QX53)

[Text version]
Cell line name MHHi002-A-1
Synonyms CF[1]iPS5-corr18b13w3C36
Accession CVCL_QX53
Resource Identification Initiative To cite this cell line use: MHHi002-A-1 (RRID:CVCL_QX53)
Comments From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
Derived from sampling site: Peripheral blood. Cell type=Endothelial colony forming cell.
Sequence variations
  • Mutation; HGNC; 1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=28925369).
  • Mutation; HGNC; 1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous; Note=By TALEN (PubMed=28925369).
Disease Cystic fibrosis (NCIt: C2975)
Cystic fibrosis (ORDO: Orphanet_586)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_QX52 (MHHi002-A)
Children:
CVCL_XI80 (MHHi002-A-2)CVCL_C4PC (MHHi002-A-6)CVCL_C4PD (MHHi002-A-7)
Sex of cell Male
Age at sampling Age unspecified
Category Induced pluripotent stem cell
Publications

PubMed=28925369; DOI=10.1016/j.scr.2017.07.010
Merkert S., Bednarski C., Gohring G., Cathomen T., Martin U.
Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN.
Stem Cell Res. 23:95-97(2017)

PubMed=31080112; DOI=10.1016/j.stemcr.2019.04.014
Merkert S., Schubert M., Olmer R., Engels L., Radetzki S., Veltman M., Scholte B.J., Zollner J., Pedemonte N., Galietta L.J.V., von Kries J.P., Martin U.
High-throughput screening for modulators of CFTR activity based on genetically engineered cystic fibrosis disease-specific iPSCs.
Stem Cell Reports 12:1389-1403(2019)

Cross-references
Cell line databases/resources hPSCreg; MHHi002-A-1
Encyclopedic resources Wikidata; Q54905556
Entry history
Entry creation15-Nov-2017
Last entry update21-Mar-2023
Version number10